EXTRACELL BIOTECHNOLOGIES

Liège ·KBO/BCE: BE 0804.532.945

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	-2159.1%	55.0%	better than 5% of 173 sector peers
Net result	€-14k	€16k	better than 24% of 173 sector peers
Equity	€-6k	€68k	better than 15% of 173 sector peers
Gross operating margin	€-14k	€41k	better than 15% of 174 sector peers
Total assets	€301	€144k	better than 5% of 174 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€301
Current assets	29/58	€301
Amounts receivable within one year	40/41	€286
Cash & bank	54/58	€15
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€301
Equity	10/15	€-6k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€-16k
Amounts payable	17/49	€7k
Amounts payable within one year	42/48	€7k
Trade debts payable within one year	44	€226
Income statement
Gross operating margin	9900	€-14k
Operating result	9901	€-14k
Financial charges	65	€25
Result before taxes	9903	€-14k
Net result for the period	9904	€-14k
Result to be appropriated	9905	€-14k

Legal nameFR	EXTRACELL BIOTECHNOLOGIES
AbbreviationFR	ExtraCell

Summary